Loading company
Just reported
Q2 FY2027 results
From Petmed Express's results release of November 10, 2026; its quarterly report has since been filed.
Revenue
Actual
$35.8M
-19% y/y
-13% q/qGuided
—
No guide given
EPS, GAAP
Actual
-$0.31
Guided
—
No guide given
Operating income, GAAP
Actual
-$6.4M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Petmed Express is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher CorporationOct 21, 2026CBGraded C, now B
MCKMckesson CorporationNov 4, 2026BAGraded B, now A
CVSCVS Health CorpNov 4, 2026BAGraded B, now A
EWEdwards Lifesciences CorporationNov 4, 2026BAGraded B, now A
GEHCGE Healthcare Technologies Inc.Oct 28, 2026CAGraded C, now A
Built from Petmed Express, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
